Long-term morbidity after infradiaphragmatic radiotherapy in young men with testicular cancer
- 15 July 1989
- Vol. 64 (2) , 404-408
- https://doi.org/10.1002/1097-0142(19890715)64:2<404::aid-cncr2820640211>3.0.co;2-7
Abstract
Long-term morbidity was evaluated in 357 patients with testicular cancer who were treated by infradiaphragmatic radiotherapy between 1970 and 1982. Myelopathy developed in four patients, radiation osteomyelitis in one, and radiation hepatitis in another after treatment. Posttreatment gastrointestinal symptoms were recorded in the medical records of 4% of patients but were mentioned by 41% of 199 who answered a questionnaire. The moderate gastrointestinal problems were recorded by 17% of the patients compared with 6% in a control group of healthy men. Postirradiation peptic ulcer occurred in 9%. A dose relationship existed, the risk of posttreatment gastrointestinal problems being less when the midplane dose was less than 40 Gy. Forty-one of 63 men who wished to do so fathered at least one child after their radiotherapy. The overall posttreatment quality of life was comparable to that of the control group. The authors conclude that the risk of major posttreatment morbidity is minimal for testicular cancer patients who undergo infradiaphragmatic radiotherapy after orchiectoimy. Slight gastrointestinal symptoms are relatively common without major impact on quality of life. Gonadal toxicity is not a significant complication. Infradiaphragmatic radiotherapy is a safe, routine adjuvant treatment of seminoma in orchiectomized patients with Stage I seminoma. The midplane dose should not exceed 36 Gy in these patients.This publication has 13 references indexed in Scilit:
- Radiotherapy for testicular seminoma stage I: Treatment results and long-term post-irradiation morbidity in 365 patientsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Testicular cancer in young norwegiansJournal of Surgical Oncology, 1988
- Complications from large field intermediate dose infradiaphragmatic radiation: An analysis of the patterns of care outcome studies for Hodgkin's disease and seminomaInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Gastrointestinal morbidity of adjuvant radiotherapy in stage I malignant teratoma of the testisRadiotherapy and Oncology, 1987
- The management of testicular seminoma: Edinburgh 1970-1981British Journal of Cancer, 1987
- Limitations to the use of surveillance as an option in the management of stage I seminomaInternational Journal of Andrology, 1987
- Radiotherapy for Stage I seminoma testis: Results of treatment and complicationsRadiotherapy and Oncology, 1986
- Post‐treatment Fertility in Patients with Testicular CancerBritish Journal of Urology, 1986
- Sexual and marital relationships after radiotherapy for seminomaUrology, 1986
- Post‐treatment Fertility in Patients with Testicular Cancer.: II. Influence of Cis‐platin‐based Combination Chemotherapy and of Retroperitoneal Surgery on Hormone and Sperm Cell ProductionBritish Journal of Urology, 1985